financetom
Business
financetom
/
Business
/
Market Chatter: TD's U.S. Compliance Penalties Could "Approach" US$4 Billion, says litigation analyst
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: TD's U.S. Compliance Penalties Could "Approach" US$4 Billion, says litigation analyst
Oct 4, 2024 8:13 PM

03:09 PM EDT, 10/04/2024 (MT Newswires) -- One litigation analyst says Toronto-Dominion Bank's ( MLWIQXX ) final settlement related to U.S. compliance lapses could be as high as US$4 billion, Bloomberg is reporting Friday.

Bloomberg News reported in August that TD said it anticipated having to pay a total of more than $3 billion in penalties related to U.S. compliance lapses amid allegations that it failed to catch money laundering and financial crimes at branches south of the border.

"The $3 billion in provisions that TD has taken over the last couple of quarters, that sets a floor for what the potential monetary penalty is going to be, but we don't really know what the final number is going to be," Elliott Stein, a senior litigation analyst of financials at Bloomberg Intelligence, said in an interview with BNN Bloomberg on Friday.

Stein said there is not a precedent for anti-money laundering penalties in amounts this high "for any bank at all," and anti-money laundering violations typically result in penalties in the "hundreds of millions of dollars."

"So this TD case, based on the provisions that they've taken, really is going to set a new bar," he said.

Stein noted that in a 2012 anti-money laundering case, HSBC took about $1.5 billion in provisions in two steps ahead of a final settlement with a $1.9 billion penalty. "So based on those numbers, we do think that TD could wind up having to pay more than the $3 billion that it has provision for," he said.

Based on provisions TD Bank has taken so far, Stein said it appears to be a "more egregious case."

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 86.37, Change: +0.58, Percent Change: +0.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JAKKS Pacific's Disguise Unit Signs Multi-Year Licensing Deal With Aniplex of America
JAKKS Pacific's Disguise Unit Signs Multi-Year Licensing Deal With Aniplex of America
Jun 18, 2024
10:37 AM EDT, 06/18/2024 (MT Newswires) -- JAKKS Pacific's ( JAKK ) Disguise business unit said Tuesday that it signed a multi-year licensing agreement with Aniplex of America covering the Demon Slayer: Kimetsu no Yaiba animated series in North America, Australia, New Zealand, LATAM, Ireland, and the UK. The deal allows Disguise to design, develop, and manufacture costume accessories based...
O-I Glass to Invest $65 Million in Electrification, Decarbonization Project for Plant in France
O-I Glass to Invest $65 Million in Electrification, Decarbonization Project for Plant in France
Jun 18, 2024
10:34 AM EDT, 06/18/2024 (MT Newswires) -- O-I Glass ( OI ) said Tuesday it plans to invest about $65 million into the electrification and decarbonization of its plant in Veauche, France. The company said one of its two furnaces will be renovated and fitted with hybrid-flex technology. The project will give the company the flexibility to replace up to...
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study
Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study
Jun 18, 2024
Tuesday, Intra-Cellular Therapies Inc ( ITCI ) released topline results from Study 502 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD).  The company expects to submit a supplemental FDA application in the second half of 2024. Lumateperone 42 mg, given once daily as adjunctive therapy to antidepressants, met the primary...
Canadian Imperial Bank Of Commerce, Bank of Nova Scotia, Bank of Montreal Ratings Affirmed by Fitch
Canadian Imperial Bank Of Commerce, Bank of Nova Scotia, Bank of Montreal Ratings Affirmed by Fitch
Jun 18, 2024
10:37 AM EDT, 06/18/2024 (MT Newswires) -- Fitch Ratings has affirmed the long-term issuer default rating and short-term issuer default rating on Canadian Imperial Bank Of Commerce's ( CM ) , Bank of Nova Scotia's ( BNS ) , and Bank of Montreal's ( NRGD ) at AA- and F1+, respectively. Also, Fitch affirmed the ratings of the bank's subsidiaries...
Copyright 2023-2026 - www.financetom.com All Rights Reserved